Heidi Health
Global ambient AI scribe that generates structured clinical notes from the patient encounter, with the broadest language coverage in the category. The vendor reports more than 2.5 million consults a week across 110 languages, 190 countries, and over 200 specialties. The product has expanded beyond documentation: Heidi Evidence (launched February 2026) surfaces cited clinical decision support from BMJ, NICE, and HealthPathways at the point of care, and Heidi Comms coordinates patient calls. Pricing is published, which is rare in this category. Founded in Melbourne by Dr Thomas Kelly, a former vascular surgical resident; raised a $65 million Series B in October 2025 led by Point72 Private Investments.
Capability Axes
Ambient capture and note generation is the product, extended by Heidi Evidence for cited clinical decision support and Heidi Comms for patient call coordination. All three are model driven.
Volume is substantial and consistently reported at more than 2.5 million consults a week. Known product limits are unusually candid in third party review, including that the scribe does not adaptively learn a clinician's writing style and that multi problem visits document less reliably than single problem encounters. No published accuracy study against ground truth transcripts was retrieved.
HIPAA compliance is stated, but an organization wide Business Associate Agreement is reported as available only from the Practice tier upward. A BAA gated behind an upper pricing tier is a material procurement constraint for any US organization handling PHI, and buyers on lower tiers should not assume coverage.
HIPAA, ISO 27001, and SOC 2 Type II all stated, with the specific engineering commitment that no audio is stored after transcription. Held back from A because no public trust center with control level detail or audit dates was retrieved.
Push to chart integration with systems including Epic and Oracle Health exists but is gated to the Practice and Enterprise tiers; individual and lower tiers rely on templates and copy workflows. Capability is real but commercially restricted, which is a materially different buyer experience from natively embedded competitors.
The strongest pricing disclosure in the index. Real published tiers with amounts: a free tier with unlimited transcription, Clinician at $150 per user per month billed annually, an Evidence Plus tier reported near $40, plus Practice and Enterprise tiers. A buyer can determine cost without a sales call, which is what this axis rewards. Note that sources conflict on some tier amounts and pricing was restructured in February 2026.
Coverage is stated with unusual precision and breadth: 110 languages across 190 countries and more than 200 specialties. The language coverage in particular is the clearest differentiator in this category.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Free tier; $150 per user per month for Clinician
$150 baseline
|
Per user per month, billed annually, with a free tier and quote based Practice and Enterprise tiers | Organization wide BAA reported available only from the Practice tier upward | — | Vendor Published |
Published tiers, restructured February 2026. Free tier includes unlimited transcription and 10 Pro Actions a month. Clinician is $150 per user per month billed annually; an Evidence Plus tier is reported near $40. Practice adds push to chart EHR integrations and Enterprise adds SSO and custom hosting, both quote based. Two gates matter for US buyers: EHR write back and an organization wide Business Associate Agreement are both reported as available only from the Practice tier upward. Sources conflict on some tier amounts; a 14 day trial is offered on paid plans.